These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16299941)

  • 1. Zoledronic acid(ZOMETA): a significant improvement in the bone metastases.
    Nagy Z
    Pathol Oncol Res; 2005; 11(3):186-7. PubMed ID: 16299941
    [No Abstract]   [Full Text] [Related]  

  • 2. Zometa in the treatment of diseminated prostate cancer.
    Djokic M
    Acta Chir Iugosl; 2005; 52(4):119-21. PubMed ID: 16673608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid : a review of its use in the management of bone metastases of malignancy.
    Dhillon S; Lyseng-Williamson KA
    Drugs; 2008; 68(4):507-34. PubMed ID: 18318568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer bone metastases: denosumab or zoledronic acid?
    van der Pluijm G
    Nat Rev Endocrinol; 2011 Mar; 7(3):134-5. PubMed ID: 21343953
    [No Abstract]   [Full Text] [Related]  

  • 5. [Zoledronic acid and bone pathology in the course of neoplasia. Part I].
    Caffo O
    Tumori; 2005; 91(5):22-6. PubMed ID: 16459649
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone markers for monitoring efficacy in patients 
with bone metastases receiving zoledronic acid: 
a review of published data.
    Huang Q; Ouyang X
    Int J Biol Markers; 2013 Sep; 28(3):242-8. PubMed ID: 23661577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zoledronic acid palliation in bone-metastatic breast cancer.
    Furlow B
    Lancet Oncol; 2006 Nov; 7(11):894. PubMed ID: 17099983
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
    Tomoo T; Suzuki M
    Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
    [No Abstract]   [Full Text] [Related]  

  • 9. Zoledronic acid in genitourinary cancer.
    Climent MA; Anido U; Méndez-Vidal MJ; Puente J
    Clin Transl Oncol; 2013 Nov; 15(11):871-8. PubMed ID: 23615978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of zoledronic acid and 153Sm-EDTMP in hormone-refractory prostate cancer patients with bone metastases.
    Lam MG; Dahmane A; Stevens WH; van Rijk PP; de Klerk JM; Zonnenberg BA
    Eur J Nucl Med Mol Imaging; 2008 Apr; 35(4):756-65. PubMed ID: 18157530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of bone metastases in patients with high-risk nonmetastatic prostate cancer treated with zoledronic acid: efficacy and safety results of the Zometa European Study (ZEUS).
    Wirth M; Tammela T; Cicalese V; Gomez Veiga F; Delaere K; Miller K; Tubaro A; Schulze M; Debruyne F; Huland H; Patel A; Lecouvet F; Caris C; Witjes W
    Eur Urol; 2015 Mar; 67(3):482-91. PubMed ID: 24630685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases.
    McKeage K; Plosker GL
    Pharmacoeconomics; 2008; 26(3):251-68. PubMed ID: 18282018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Zoledronic acid and osseous pathologies in the course of neoplasia. Part II].
    Caffo O
    Tumori; 2005; 91(6):suppl 23-7. PubMed ID: 16457163
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of zoledronic acid in pediatric cancer patients.
    August KJ; Dalton A; Katzenstein HM; George B; Olson TA; Wasilewski-Masker K; Rapkin LB
    Pediatr Blood Cancer; 2011 Apr; 56(4):610-4. PubMed ID: 21298747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bone metastases in lung cancer: the actual role of zoledronic acid.
    Ricciardi S; de Marinis F
    Rev Recent Clin Trials; 2009 Sep; 4(3):205-11. PubMed ID: 20028333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of zoledronic acid in cancer: clinical studies in the treatment and prevention of bone metastases.
    Coleman RE; Seaman JJ
    Semin Oncol; 2001 Apr; 28(2 Suppl 6):11-6. PubMed ID: 11346860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Words of Wisdom. Re: Randomized Controlled Trial of Early Zoledronic Acid in Men with Castration-sensitive Prostate Cancer and Bone Metastases: Results of CALGB 90202 (Alliance).
    Kimura T; Egawa S
    Eur Urol; 2016 Apr; 69(4):754-5. PubMed ID: 26972498
    [No Abstract]   [Full Text] [Related]  

  • 18. Symptomatic hypocalcemia following intravenous administration of zoledronic acid in a breast cancer patient.
    Mishra A
    J Postgrad Med; 2008; 54(3):237. PubMed ID: 18626181
    [No Abstract]   [Full Text] [Related]  

  • 19. Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases.
    Niikura N; Liu J; Hayashi N; Palla SL; Tokuda Y; Hortobagyi GN; Ueno NT; Theriault RL
    Cancer; 2012 Apr; 118(8):2039-47. PubMed ID: 22139648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid (Zometa): bisphosphonate for prostate cancer/bone metastases.
    Gaines KK
    Urol Nurs; 2002 Dec; 22(6):398-400. PubMed ID: 12593231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.